Patterns of failure after stereotactic body radiation therapy or lobar resection for clinical stage I non-small-cell lung cancer.

Autor: Robinson CG, Dewees TA, El Naqa IM, Creach KM, Olsen JR, Crabtree TD, Meyers BF, Puri V, Bell JM, Parikh PJ, Bradley JD

Publikováno v: Journal of Thoracic Oncology; 2013 Feb, Vol. 8 Issue 2, p192-201, 10p

A Phase 1/2 Study of Disulfiram and Copper With Concurrent Radiation Therapy and Temozolomide for Patients With Newly Diagnosed Glioblastoma.

Autor: Huang J; Department of Radiation Oncology, Washington University School of Medicine, St Louis, Missouri; Brain Tumor Center, Siteman Cancer Center, Washington University School of Medicine, St Louis, Missouri. Electronic address: jiayi.huang@wustl.edu., Campian JL; Division of Medical Oncology, Department of Medicine, Washington University School of Medicine, St Louis, Missouri; Division of Medical Oncology, Department of Oncology, Mayo Clinic, Rochester, Minnesota., DeWees TA; Department of Radiation Oncology, Washington University School of Medicine, St Louis, Missouri; Department of Computational and Quantitative Medicine, Radiation Oncology, Surgery, Division of Biostatistics, City of Hope, Duarte, California., Skrott Z; Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic., Mistrik M; Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic., Johanns TM; Brain Tumor Center, Siteman Cancer Center, Washington University School of Medicine, St Louis, Missouri; Division of Medical Oncology, Department of Medicine, Washington University School of Medicine, St Louis, Missouri., Ansstas G; Brain Tumor Center, Siteman Cancer Center, Washington University School of Medicine, St Louis, Missouri; Division of Medical Oncology, Department of Medicine, Washington University School of Medicine, St Louis, Missouri., Butt O; Brain Tumor Center, Siteman Cancer Center, Washington University School of Medicine, St Louis, Missouri; Division of Medical Oncology, Department of Medicine, Washington University School of Medicine, St Louis, Missouri., Leuthardt E; Brain Tumor Center, Siteman Cancer Center, Washington University School of Medicine, St Louis, Missouri; Department of Neurological Surgery, Washington University School of Medicine, St Louis, Missouri., Dunn GP; Brain Tumor Center, Siteman Cancer Center, Washington University School of Medicine, St Louis, Missouri; Department of Neurological Surgery, Washington University School of Medicine, St Louis, Missouri., Zipfel GJ; Brain Tumor Center, Siteman Cancer Center, Washington University School of Medicine, St Louis, Missouri; Department of Neurological Surgery, Washington University School of Medicine, St Louis, Missouri., Osbun JW; Department of Neurological Surgery, Washington University School of Medicine, St Louis, Missouri., Abraham C; Department of Radiation Oncology, Washington University School of Medicine, St Louis, Missouri; Brain Tumor Center, Siteman Cancer Center, Washington University School of Medicine, St Louis, Missouri., Badiyan S; Department of Radiation Oncology, Washington University School of Medicine, St Louis, Missouri., Schwetye K; Department of Pathology and Immunology, Washington University School of Medicine, St Louis, Missouri., Cairncross JG; Clark H. Smith Brain Tumour Centre, Charbonneau Cancer Institute, University of Calgary, Calgary, Alberta, Canada., Rubin JB; Department of Pediatrics, Washington University School of Medicine, St Louis, Missouri; Department of Neuroscience, Washington University School of Medicine, St Louis, Missouri., Kim AH; Brain Tumor Center, Siteman Cancer Center, Washington University School of Medicine, St Louis, Missouri; Department of Neurological Surgery, Washington University School of Medicine, St Louis, Missouri., Chheda MG; Brain Tumor Center, Siteman Cancer Center, Washington University School of Medicine, St Louis, Missouri; Division of Medical Oncology, Department of Medicine, Washington University School of Medicine, St Louis, Missouri.

Publikováno v: International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2024 Nov 01; Vol. 120 (3), pp. 738-749. Date of Electronic Publication: 2024 May 19.

Multicenter Multivendor Evaluation of Dose Volume Histogram Creation Consistencies for 8 Commercial Radiation Therapy Dosimetric Systems.

Autor: Penoncello GP; Department of Radiation Oncology, Mayo Clinic, Phoenix, Arizona; Department of Radiation Oncology, University of Colorado, Aurora, Colorado., Voss MM; Division of Biomedical Statistics and Informatics, Mayo Clinic, Scottsdale, Arizona., Gao Y; Department of Radiation Oncology, Stanford University, Palo Alto, California., Sensoy L; Department of Radiation Oncology, University of Miami, Miami, Florida., Cao M; Department of Radiation Oncology, University of California Los Angeles, Los Angeles, California., Pepin MD; Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota., Herchko SM; Department of Radiation Oncology, Mayo Clinic, Jacksonville, Florida., Benedict SH; Department of Radiation Oncology, University of California Davis, Sacramento, California., DeWees TA; Department of Computational and Quantitative Medicine, City of Hope, Duarte, California; Department of Radiation Oncology, City of Hope, Duarte, California. Electronic address: tdewees@coh.org., Rong Y; Department of Radiation Oncology, Mayo Clinic, Phoenix, Arizona. Electronic address: rong.yi@mayo.edu.

Publikováno v: Practical radiation oncology [Pract Radiat Oncol] 2024 May-Jun; Vol. 14 (3), pp. e236-e248. Date of Electronic Publication: 2023 Oct 31.

Physician- and Patient-Reported Outcomes of the MC1635 Phase 3 Trial of Ultrahypofractionated Versus Moderately Hypofractionated Adjuvant Radiation Therapy After Breast-Conserving Surgery.

Autor: Laughlin BS; Department of Radiation Oncology, Mayo Clinic, Phoenix, Arizona., Corbin KS; Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota., Toesca DAS; Department of Radiation Oncology, Mayo Clinic, Phoenix, Arizona., Thorpe CS; Department of Radiation Oncology, Sanford Health, Fargo, North Dakota., Golafshar MA; Department of Qualitative Health Sciences, Section of Biostatistics, Mayo Clinic, Scottsdale, Arizona., Pockaj B; Department of General Surgery, Mayo Clinic, Phoenix, Arizona., Cronin P; Department of General Surgery, Mayo Clinic, Phoenix, Arizona., McGee LA; Department of Radiation Oncology, Mayo Clinic, Phoenix, Arizona., Halyard MY; Department of Radiation Oncology, Mayo Clinic, Phoenix, Arizona., Mutter RW; Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota., Keole SR; Department of Radiation Oncology, Mayo Clinic, Phoenix, Arizona., Park SS; Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota., Shumway DA; Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota., Vern-Gross TZ; Department of Radiation Oncology, Mayo Clinic, Phoenix, Arizona., Vallow L; Department of Radiation Oncology, Mayo Clinic, Jacksonville, Florida., Wong WW; Department of Radiation Oncology, Mayo Clinic, Phoenix, Arizona., DeWees TA; Department of Qualitative Health Sciences, Section of Biostatistics, Mayo Clinic, Scottsdale, Arizona., Vargas CE; Department of Radiation Oncology, Mayo Clinic, Phoenix, Arizona. Electronic address: Vargas.Carlos@mayo.edu.

Publikováno v: International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2024 Mar 15; Vol. 118 (4), pp. 1049-1059. Date of Electronic Publication: 2023 Oct 31.

Dosimetric comparison between proton beam therapy, intensity modulated radiation therapy, and 3D conformal therapy for soft tissue extremity sarcoma.

Autor: Laughlin BS; Department of Radiation Oncology, Mayo Clinic, Phoenix, AZ, USA., Golafshar M; Department of Quanitative Health Sciences, Section of Biostatistics, Mayo Clinic, Scottsdale, AZ, USA., Prince M; Department of Radiation Oncology, Mayo Clinic, Phoenix, AZ, USA., Liu W; Department of Radiation Oncology, Mayo Clinic, Phoenix, AZ, USA., Kutyreff CJ; Department of Radiation Oncology, Mayo Clinic, Phoenix, AZ, USA., Ahmed SK; Department of Radiation Oncology, Mayo Clinic, Phoenix, AZ, USA., Vern Gross TZ; Department of Radiation Oncology, Mayo Clinic, Phoenix, AZ, USA., Haddock M; Department of Radiation Oncology, Mayo Clinic, Rochester, MN, USA., Petersen I; Department of Radiation Oncology, Mayo Clinic, Rochester, MN, USA., DeWees TA; Department of Quanitative Health Sciences, Section of Biostatistics, Mayo Clinic, Scottsdale, AZ, USA., Ashman JB; Department of Radiation Oncology, Mayo Clinic, Phoenix, AZ, USA.

Publikováno v: Acta oncologica (Stockholm, Sweden) [Acta Oncol] 2023 May; Vol. 62 (5), pp. 473-479. Date of Electronic Publication: 2023 May 08.